{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:09:51Z","timestamp":1792638591787,"version":"4.5.0"},"publisher-location":"New York, NY","reference-count":33,"publisher":"Springer New York","isbn-type":[{"value":"9781493971404","type":"print"},{"value":"9781493971428","type":"electronic"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-1-4939-7142-8_4","type":"book-chapter","created":{"date-parts":[[2017,7,22]],"date-time":"2017-07-22T11:07:18Z","timestamp":1500721638000},"page":"51-73","source":"Crossref","is-referenced-by-count":13,"title":["Immunophenotyping by Multiparameter Flow Cytometry"],"prefix":"10.1007","author":[{"given":"Weina","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung S.","family":"Luu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,23]]},"reference":[{"key":"4_CR1","volume-title":"World Health Organization classification of tumors of haematopoietic and lymphoid tissues","year":"2008","unstructured":"Swerdlow SH, Campo E, Harrris NL et al (eds) (2008) World Health Organization classification of tumors of haematopoietic and lymphoid tissues, 4th edn. WHO Press, Geneva, Switzerland","edition":"4"},{"key":"4_CR2","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1182\/blood-2007-11-120535","volume":"111","author":"FE Craig","year":"2008","unstructured":"Craig FE, Foon KA (2008) Flow cytometric immunophenotyping for hematologic neoplasms. Blood 111:3941\u20133967","journal-title":"Blood"},{"key":"4_CR3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.5858\/2003-127-42-FCAOA","volume":"127","author":"Z Kaleem","year":"2003","unstructured":"Kaleem Z, Crawford E, Pathan MH et al (2003) Flow cytometric analysis of acute leukemias. Diagnostic utility and critical analysis of data. Arch Pathol Lab Med 127:42\u201348","journal-title":"Arch Pathol Lab Med"},{"key":"4_CR4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/B978-0-12-385493-3.00010-3","volume":"103","author":"W Gorczyca","year":"2011","unstructured":"Gorczyca W, Sun ZY, Cronin W et al (2011) Immunophenotypic pattern of myeloid populations by flow cytometry analysis. Methods Cell Biol 103:221\u2013266","journal-title":"Methods Cell Biol"},{"key":"4_CR5","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/modpathol.3800168","volume":"17","author":"H Khoury","year":"2004","unstructured":"Khoury H, Dalal BI, Nantel SH et al (2004) Correlation between karyotype and quantitative immunophenotype in acute myelogenous leukemia with t(8;21). Mod Pathol 17:1211\u20131216","journal-title":"Mod Pathol"},{"key":"4_CR6","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1182\/blood.V80.2.470.470","volume":"80","author":"K Kita","year":"1992","unstructured":"Kita K, Nakase K, Miwa H et al (1992) Phenotypical characteristics of acute myelocytic leukemia associated with the t(8;21)(q22;q22) chromosomal abnormality: frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34. Blood 80:470\u2013477","journal-title":"Blood"},{"key":"4_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cyto.b.20001","volume":"59","author":"E Paietta","year":"2004","unstructured":"Paietta E, Goloubeva O, Neuberg D et al (2004) A surrogate marker profile for PML\/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes. Cytometry B Clin Cytom 59:1\u20139","journal-title":"Cytometry B Clin Cytom"},{"key":"4_CR8","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1309\/XC8P9M8NKQDT38LB","volume":"121","author":"P Lin","year":"2004","unstructured":"Lin P, Hao S, Medeiros LJ et al (2004) Expression of CD2 in acute promyelocytic leukemia correlates with short form of PML-RARalpha transcripts and poorer prognosis. Am J Clin Pathol 121:402\u2013407","journal-title":"Am J Clin Pathol"},{"key":"4_CR9","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1182\/blood-2004-03-1036","volume":"104","author":"W Kern","year":"2004","unstructured":"Kern W, Voskova D, Schoch C et al (2004) Determination of relapse risk based on assessment of minimal residual disease during complete remission by multiparameter flow cytometry in unselected patients with acute myeloid leukemia. Blood 104:3078\u20133085","journal-title":"Blood"},{"key":"4_CR10","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1182\/blood.V98.6.1746","volume":"98","author":"JF San Miguel","year":"2001","unstructured":"San Miguel JF, Vidriales MB, Lopez-Berges C et al (2001) Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification. Blood 98:1746\u20131751","journal-title":"Blood"},{"key":"4_CR11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/(SICI)1097-0320(19990815)38:4<139::AID-CYTO1>3.0.CO;2-H","volume":"38","author":"D Campana","year":"1999","unstructured":"Campana D, Coustan-Smith E (1999) Detection of minimal residual disease in acute leukemia by flow cytometry. Cytometry 38:139\u2013152","journal-title":"Cytometry"},{"key":"4_CR12","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1182\/blood-2008-01-132837","volume":"111","author":"MJ Borowitz","year":"2008","unstructured":"Borowitz MJ, Devidas M, Hunger SP et al (2008) Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's oncology group study. Blood 111:5477\u20135485","journal-title":"Blood"},{"key":"4_CR13","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1182\/blood-2015-03-633685","volume":"126","author":"MJ Borowitz","year":"2015","unstructured":"Borowitz MJ, Wood BL, Devidas M et al (2015) Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children\u2019s oncology group study AALL0232. Blood 126:964\u2013971","journal-title":"Blood"},{"key":"4_CR14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1200\/JCO.2015.63.3826","volume":"34","author":"D Araki","year":"2015","unstructured":"Araki D, Wood BL, Othus M et al (2015) Allogeneic hematopoietic cell transplantation for acute myeloid leukemia: time to move toward a minimal residual disease-based definition of complete remission? J Clin Oncol 34:329\u2013336","journal-title":"J Clin Oncol"},{"key":"4_CR15","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1182\/blood-2009-12-258178","volume":"116","author":"F Buccisano","year":"2010","unstructured":"Buccisano F, Maurillo L, Spagnoli A et al (2010) Cytogenetic and molecular diagnostic characterization combined to postconsolidation minimal residual disease assessment by flow cytometry improves risk stratification in adult acute myeloid leukemia. Blood 116:2295\u20132303","journal-title":"Blood"},{"key":"4_CR16","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1038\/leu.2012.122","volume":"26","author":"T Kalina","year":"2012","unstructured":"Kalina T, Flores-Montero J, van der Velden VH et al (2012) EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols. Leukemia 26:1986\u20132010","journal-title":"Leukemia"},{"key":"4_CR17","doi-asserted-by":"crossref","first-page":"680","DOI":"10.5858\/2006-130-680-CACFCI","volume":"130","author":"B Wood","year":"2006","unstructured":"Wood B (2006) 9-color and 10-color flow cytometry in the clinical laboratory. Arch Pathol Lab Med 130:680\u2013690","journal-title":"Arch Pathol Lab Med"},{"key":"4_CR18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1749-6632.1993.tb38783.x","volume":"677","author":"GT Stelzer","year":"1993","unstructured":"Stelzer GT, Shults KE, Loken MR (1993) CD45 gating for routine flow cytometric analysis of human bone marrow specimens. Ann N Y Acad Sci 677:265\u2013280","journal-title":"Ann N Y Acad Sci"},{"key":"4_CR19","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/ajcp\/100.5.534","volume":"100","author":"MJ Borowitz","year":"1993","unstructured":"Borowitz MJ, Guenther KL, Shults KE et al (1993) Immunophenotyping of acute leukemia by flow cytometric analysis. Use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis. Am J Clin Pathol 100:534\u2013540","journal-title":"Am J Clin Pathol"},{"key":"4_CR20","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1309\/AJCPN4G1IZPABRLH","volume":"137","author":"AM Harrington","year":"2012","unstructured":"Harrington AM, Olteanu H, Kroft SH (2012) A dissection of the CD45\/side scatter \u201cblast gate\u201d. Am J Clin Pathol 137:800\u2013804","journal-title":"Am J Clin Pathol"},{"key":"4_CR21","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/sj.leu.2404242","volume":"20","author":"Y Xu","year":"2006","unstructured":"Xu Y, McKenna RW, Wilson KS et al (2006) Immunophenotypic identification of acute myeloid leukemia with monocytic differentiation. Leukemia 20:1321\u20131324","journal-title":"Leukemia"},{"key":"4_CR22","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.cll.2007.05.006","volume":"27","author":"BL Wood","year":"2003","unstructured":"Wood BL (2003) Myeloid malignancies: myelodysplastic syndromes, myeloproliferative disorders, and acute myeloid leukemia. Clin Lab Med 27:551\u2013575","journal-title":"Clin Lab Med"},{"key":"4_CR23","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.5858\/2003-127-1140-UCFCTI","volume":"127","author":"SJ Kussick","year":"2003","unstructured":"Kussick SJ, Wood BL (2003) Using 4-color flow cytometry to identify abnormal myeloid populations. Arch Pathol Lab Med 127:1140\u20131147","journal-title":"Arch Pathol Lab Med"},{"key":"4_CR24","doi-asserted-by":"crossref","unstructured":"Fuda F, Chen W (2014) Lineage determination in mixed phenotype acute leukemia: response to Marcondes et al. Cytometry B Clin Cytom 86:150\u2013151","DOI":"10.1002\/cyto.b.21159"},{"key":"4_CR25","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1309\/AJCP5TSD3DZXFLCX","volume":"131","author":"A Al-Mawali","year":"2009","unstructured":"Al-Mawali A, Gillis D, Lewis I (2009) The role of multiparameter flow cytometry for detection of minimal residual disease in acute myeloid leukemia. Am J Clin Pathol 131:16\u201326","journal-title":"Am J Clin Pathol"},{"key":"4_CR26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/cncr.23128","volume":"112","author":"W Kern","year":"2008","unstructured":"Kern W, Haferlach C, Haferlach T et al (2008) Monitoring of minimal residual disease in acute myeloid leukemia. Cancer 112:4\u201316","journal-title":"Cancer"},{"key":"4_CR27","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1002\/cncr.24610","volume":"115","author":"W Chen","year":"2009","unstructured":"Chen W, Konoplev S, Medeiros LJ et al (2009) Cuplike nuclei (prominent nuclear invaginations) in acute myeloid leukemia are highly associated with FLT3 internal tandem duplication and NPM1 mutation. Cancer 115:5481\u20135489","journal-title":"Cancer"},{"key":"4_CR28","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1038\/sj.leu.2403458","volume":"18","author":"SJ Kussick","year":"2004","unstructured":"Kussick SJ, Stirewalt DL, Yi HS et al (2004) A distinctive nuclear morphology in acute myeloid leukemia is strongly associated with loss of HLA-DR expression and FLT3 internal tandem duplication. Leukemia 18:1591\u20131598","journal-title":"Leukemia"},{"key":"4_CR29","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.humpath.2012.05.003","volume":"43","author":"D Rakheja","year":"2012","unstructured":"Rakheja D, Konoplev S, Medeiros LJ et al (2012) IDH mutations in acute myeloid leukemia. Hum Pathol 43:1541\u20131551","journal-title":"Hum Pathol"},{"key":"4_CR30","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1309\/T903Y1FY5WKK9EEY","volume":"124","author":"DT Yang","year":"2005","unstructured":"Yang DT, Greenwood JH, Hartung L et al (2005) Flow cytometric analysis of different CD14 epitopes can help identify immature monocytic populations. Am J Clin Pathol 124:930\u2013936","journal-title":"Am J Clin Pathol"},{"key":"4_CR31","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1309\/XREF-C9T2-6U0A-4EDT","volume":"116","author":"NJ Karandikar","year":"2001","unstructured":"Karandikar NJ, Aquino DB, McKenna RW et al (2001) Transient myeloproliferative disorder and acute myeloid leukemia in down syndrome. An immunophenotypic analysis. Am J Clin Pathol 116:204\u2013210","journal-title":"Am J Clin Pathol"},{"key":"4_CR32","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/cyto.b.21198","volume":"88","author":"L Wang","year":"2015","unstructured":"Wang L, Peters JM, Fuda F et al (2015) Acute megakaryoblastic leukemia associated with trisomy 21 demonstrates a distinct immunophenotype. Cytometry B Clin Cytom 88:244\u2013252","journal-title":"Cytometry B Clin Cytom"},{"key":"4_CR33","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/leu.2008.388","volume":"23","author":"T Haferlach","year":"2009","unstructured":"Haferlach T, Kohlmann A, Klein HU et al (2009) AML with translocation t(8;16)(p11;p13) demonstrates unique cytomorphological, cytogenetic, molecular and prognostic features. Leukemia 23:934\u2013943","journal-title":"Leukemia"}],"container-title":["Methods in Molecular Biology","Acute Myeloid Leukemia"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-7142-8_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T09:58:44Z","timestamp":1659261524000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-7142-8_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9781493971404","9781493971428"],"references-count":33,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-7142-8_4","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}